Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated to version 2.14.1 on January 17, 2025, following the removal of version 2.14.0 on December 20, 2024.SummaryDifference1%
- Check24 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check46 days agoChange DetectedA new addition was made on December 20, 2024, while a deletion occurred on November 25, 2024.SummaryDifference0.7%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.